Global Markets Direct’s, ‘Nicotine Addiction – Pipeline Review, H1 2015’, provides an overview of the Nicotine Addiction’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Nicotine Addiction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Nicotine Addiction and special features on late-stage and discontinued projects.
For more information, visit here:
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
• Devise corrective measures for pipeline projects by understanding Nicotine Addiction pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Latest Report by Radiant Insights:
Cystic Fibrosis Therapeutics in Major Developed Markets to 2019:
GBI Research, a leading business intelligence provider, has released its latest research report “Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 – CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth”. The value of the Cystic Fibrosis (CF) market is expected to increase significantly in value over the forecast period across the leading eight developed nations, from $695.6 million in 2012 to almost $4.5 billion in 2019.
Mexico Nuclear Imaging Equipment Market Outlook to 2020:
GlobalData’s new report, “Mexico Nuclear Imaging Equipment Market Outlook to 2020”, provides key market data on the Mexico Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories – Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems).
To browse more sample reports of this category, visit Radiant Insights
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: Send Email
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States